Mission Statement
The Department of Urology strives to develop innovative ways to advance the diagnosis and treatment of urologic diseases, and educate the next generation of leaders in the field.

Support UIC Urology


Movember 2016 

It’s that time again and the Urology team is striving to have an impact on the face of men’s health. Movember is an annual movement where men grow a mustache to raise awareness about men’s health - prostate cancertesticular cancer and mental health issues such as depression.

We encourage everyone to join our team, #UICGotMustache, on the Movember website

UIC Movember 3V3 Basketball Tournament and Men’s Health Fair
Saturday, November 20
11:00am – 3:00pm
UIC East Campus Student Recreation Facility
Registration $20 per team and each team can have 4 players.
Click HERE to register.

Testing for Prostate Cancer  - Questions and Answers

Prostate Cancer is the most common type of cancer for men, except skin cancer. Smart PSA testing raises the chance of finding a dangerous cancer and treating before it spreads. Read our brochure and speak to your primary care provider to request a test.

02/12/2016:  Prostate Cancer Researcher Is Collaborator on Large DoD Award

Michael Abern, M.D., assistant professor and director of urologic oncology and a widely respected expert on prostate cancer, is a collaborator on a nearly $600,000 prostate cancer research grant awarded by the U.S. Department of Defense (DoD), the Department of Urology announced.

Dr. Abern, whose ongoing work with DoD will contribute to the three-year project, will collaborate with Larisa Nonn, Ph.D. associate professor of pathology, said Craig Niederberger, M.D., professor and head of the Department and professor of bioengineering.

The grant is part of the Congressionally Directed Medical Research Programs of the U.S. Army’s Medical Research and Materiel.  The clinical test Drs. Nonn and Abern will conduct relates to the role of serum microRNAs, also known as miRs, that are associated with low-risk prostate cancer.  Their research investigates the biological significance of miRs and whether they originate in the prostate or elsewhere.

“The research is critical toward understanding the biology of prostate cancer,” said Dr. Abern. “Confirmation of miRs’ role could help lead to improved risk stratification - and ultimately treatment decisions - that go beyond the prostate-specific antigen (PSA) method, the current resource typically employed.  A test that will predict the behavior of prostate cancer would be a critical step in determining what the best treatment strategy will be for our patients.”

09/19/2015: Gail S. Prins, Ph.D. received the ‘Innovator of Today Alumni Award’ from the College of Medicine during the College of Medicine Gala on September 19, 2015. Click here to find out more details. 

UIC Urology is now on facebook and twitter
Facebook Twitter